Aman Wang

845 total citations
21 papers, 449 citations indexed

About

Aman Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Aman Wang has authored 21 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Aman Wang's work include Ubiquitin and proteasome pathways (8 papers), Cancer, Hypoxia, and Metabolism (4 papers) and RNA modifications and cancer (3 papers). Aman Wang is often cited by papers focused on Ubiquitin and proteasome pathways (8 papers), Cancer, Hypoxia, and Metabolism (4 papers) and RNA modifications and cancer (3 papers). Aman Wang collaborates with scholars based in China, United States and Italy. Aman Wang's co-authors include Jiwei Liu, Zhen Ning, Qiu Yan, Jinxiao Liang, Jinxiao Liang, Yunpeng Xie, Chang Lu, Zhongyu Wang, Guang Tan and Jie Ren and has published in prestigious journals such as Oncogene, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Aman Wang

20 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aman Wang China 13 344 162 133 73 51 21 449
Zhuonan Liu China 8 445 1.3× 132 0.8× 159 1.2× 83 1.1× 53 1.0× 12 529
Yun Seong Jeong United States 9 397 1.2× 147 0.9× 143 1.1× 40 0.5× 41 0.8× 17 499
Ranran Kong China 14 331 1.0× 107 0.7× 189 1.4× 67 0.9× 51 1.0× 37 445
Shoujie Chai China 10 239 0.7× 204 1.3× 143 1.1× 109 1.5× 42 0.8× 12 431
Xun‐Xun Wan China 9 331 1.0× 149 0.9× 165 1.2× 50 0.7× 39 0.8× 9 458
Gabriela Koifman Israel 11 342 1.0× 261 1.6× 150 1.1× 34 0.5× 37 0.7× 12 486
Robert Vander Broek United States 8 334 1.0× 163 1.0× 145 1.1× 83 1.1× 41 0.8× 8 469
Mianen Sun United States 8 279 0.8× 108 0.7× 106 0.8× 46 0.6× 26 0.5× 17 357
Qiqi Shi China 9 322 0.9× 89 0.5× 161 1.2× 34 0.5× 57 1.1× 16 458
Chune Yu China 10 236 0.7× 181 1.1× 117 0.9× 60 0.8× 90 1.8× 15 413

Countries citing papers authored by Aman Wang

Since Specialization
Citations

This map shows the geographic impact of Aman Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aman Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aman Wang more than expected).

Fields of papers citing papers by Aman Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aman Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aman Wang. The network helps show where Aman Wang may publish in the future.

Co-authorship network of co-authors of Aman Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Aman Wang. A scholar is included among the top collaborators of Aman Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aman Wang. Aman Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yan-Song, et al.. (2025). Peripheral inflammatory factors as prognostic predictors for first-line PD-1/PD-L1 inhibitors in advanced non-small cell lung cancer. Scientific Reports. 15(1). 11206–11206. 4 indexed citations
2.
Wang, Aman & Jiwei Liu. (2025). From awareness to action: Revolutionizing cardio-oncology in China. Seminars in Cancer Biology. 114. 195–202.
3.
Dai, Rui, et al.. (2024). Glycan-based scaffolds and nanoparticles as drug delivery system in cancer therapy. Frontiers in Immunology. 15. 1395187–1395187. 5 indexed citations
4.
Sun, Rui, Xin Guo, Lei Fang, et al.. (2023). RIOK3 promotes mTORC1 activation by facilitating SLC7A2-mediated arginine uptake in pancreatic ductal adenocarcinoma. Aging. 15(4). 1039–1051. 5 indexed citations
5.
Wang, Lei, Wuxiyar Otkur, Aman Wang, et al.. (2022). Norcantharidin overcomes vemurafenib resistance in melanoma by inhibiting pentose phosphate pathway and lipogenesis via downregulating the mTOR pathway. Frontiers in Pharmacology. 13. 906043–906043. 7 indexed citations
6.
Xu, Mengyuan, Lei Fang, Xin Guo, et al.. (2022). RIOK3 promotes pancreatic ductal adenocarcinoma cell invasion and metastasis by stabilizing FAK. Heliyon. 8(8). e10116–e10116. 4 indexed citations
7.
Liu, Chang, Huiying Liu, Zeming Wu, et al.. (2022). Tissue metabolomics identified new biomarkers for the diagnosis and prognosis prediction of pancreatic cancer. Frontiers in Oncology. 12. 991051–991051. 8 indexed citations
8.
Zhang, Xu, Xiao-Min Yu, Min Zhang, et al.. (2021). Efficacy and safety of endostatin in combination with chemotherapy in small cell lung cancer: a phase 2 single-arm multicenter open-label trial. Annals of Palliative Medicine. 10(3). 3277–3285. 5 indexed citations
9.
Safi, Mohammed, Mahmoud Al‐Azab, Dario Trapani, et al.. (2021). Age-Based Disparities in Metastatic Melanoma Patients Treated in the Immune Checkpoint Inhibitors (ICI) Versus Non-ICI Era: A Population-Based Study. Frontiers in Immunology. 12. 609728–609728. 12 indexed citations
10.
Yang, Lu-Ping, Zixian Wang, Rui Zhang, et al.. (2021). Association between cigarette smoking and colorectal cancer sidedness: A multi-center big-data platform-based analysis. Journal of Translational Medicine. 19(1). 150–150. 14 indexed citations
11.
Ren, Jie, Aman Wang, Jiwei Liu, & Qihang Yuan. (2021). Identification and validation of a novel redox-related lncRNA prognostic signature in lung adenocarcinoma. Bioengineered. 12(1). 4331–4348. 35 indexed citations
12.
Lin, Zhikun, Qian Wang, Ying Li, et al.. (2021). Administration of a Probiotic Mixture Ameliorates Cisplatin-Induced Mucositis and Pica by Regulating 5-HT in Rats. Journal of Immunology Research. 2021. 1–16. 18 indexed citations
13.
Guo, Xin, Aman Wang, Wen Wang, et al.. (2020). HRD1 inhibits fatty acid oxidation and tumorigenesis by ubiquitinating CPT2 in triple‐negative breast cancer. Molecular Oncology. 15(2). 642–656. 34 indexed citations
14.
Chen, Di, Zhen Ning, Huan Chen, et al.. (2019). An integrative pan-cancer analysis of biological and clinical impacts underlying ubiquitin-specific-processing proteases. Oncogene. 39(3). 587–602. 13 indexed citations
15.
Lu, Chang, Zhen Ning, Aman Wang, et al.. (2018). USP10 suppresses tumor progression by inhibiting mTOR activation in hepatocellular carcinoma. Cancer Letters. 436. 139–148. 55 indexed citations
16.
Wang, Aman, Zhen Ning, Chang Lu, et al.. (2017). USP22 Induces Cisplatin Resistance in Lung Adenocarcinoma by Regulating γH2AX-Mediated DNA Damage Repair and Ku70/Bax-Mediated Apoptosis. Frontiers in Pharmacology. 8. 274–274. 49 indexed citations
17.
Liang, Jinxiao, Zhen Ning, Wei Gao, et al.. (2014). Ubiquitin-specific protease 22-induced autophagy is correlated with poor prognosis of pancreatic cancer. Oncology Reports. 32(6). 2726–2734. 42 indexed citations
18.
19.
Ning, Zhen, Aman Wang, Jinxiao Liang, et al.. (2014). USP22 promotes epithelial-mesenchymal transition via the FAK pathway in pancreatic cancer cells. Oncology Reports. 32(4). 1451–1458. 37 indexed citations
20.
Ning, Zhen, Aman Wang, Jinxiao Liang, et al.. (2014). Abnormal expression of Nek2 in pancreatic ductal adenocarcinoma: a novel marker for prognosis.. PubMed. 7(5). 2462–9. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhuonan Liu Breakdown of academic impact, for papers by Yun Seong Jeong Breakdown of academic impact, for papers by Ranran Kong Breakdown of academic impact, for papers by Shoujie Chai Breakdown of academic impact, for papers by Xun‐Xun Wan Breakdown of academic impact, for papers by Gabriela Koifman Breakdown of academic impact, for papers by Robert Vander Broek Breakdown of academic impact, for papers by Mianen Sun Breakdown of academic impact, for papers by Qiqi Shi Breakdown of academic impact, for papers by Chune Yu
Rankless by CCL
2026